Background. The Foundation for the National Institutes of Health Sarcopenia Project developed data-driven cut-points for clinically meaningful weakness and low lean body mass. This analysis describes strength and function response to interventions based on these classifications. Methods. In data from four intervention studies, 378 postmenopausal women with baseline and 6-month data were evaluated for change in grip strength, appendicular lean mass corrected for body mass index, leg strength and power, and short physical performance battery (SPPB). Clinical interventions included hormones, exercise, and nutritional supplementation. Differences in outcomes were evaluated between (i) those with and without weakness and (ii) those with weakness...
Background.Weakness is common and contributes to disability, but no consensus exists regarding a str...
Aging and menopause are associated with morphological and functional changes which may lead to loss ...
CONTEXT AND OBJECTIVE: Sarcopenia is the main factor involved in the development of frailty syndrome...
Background. The Foundation for the National Institutes of Health Sarcopenia Project developed data-d...
PURPOSE: To determine the prevalence of sarcopenia and investigate relationships among body composit...
Background. In the aging process, loss of muscle is relatively continuous, but the initiation, timin...
This analysis sought to determine the associations of the Foundation for the National Institutes of ...
Background.This analysis sought to determine the associations of the Foundation for the National Ins...
Low lean mass is potentially clinically important in older persons, but criteria have not been empir...
BACKGROUND: Muscle mass index has long been used as a useful index to evaluate the risks of develop...
Background.Low muscle mass and weakness are common and potentially disabling in older adults, but in...
peer-reviewedSarcopenia refers to the age-related decline in muscle mass. The criteria for the ident...
Background.Low lean mass is potentially clinically important in older persons, but criteria have not...
Background. Recommendations for identifying age-related muscle dysfunction have recently been publis...
Weakness is common and contributes to disability, but no consensus exists regarding a strength cutpo...
Background.Weakness is common and contributes to disability, but no consensus exists regarding a str...
Aging and menopause are associated with morphological and functional changes which may lead to loss ...
CONTEXT AND OBJECTIVE: Sarcopenia is the main factor involved in the development of frailty syndrome...
Background. The Foundation for the National Institutes of Health Sarcopenia Project developed data-d...
PURPOSE: To determine the prevalence of sarcopenia and investigate relationships among body composit...
Background. In the aging process, loss of muscle is relatively continuous, but the initiation, timin...
This analysis sought to determine the associations of the Foundation for the National Institutes of ...
Background.This analysis sought to determine the associations of the Foundation for the National Ins...
Low lean mass is potentially clinically important in older persons, but criteria have not been empir...
BACKGROUND: Muscle mass index has long been used as a useful index to evaluate the risks of develop...
Background.Low muscle mass and weakness are common and potentially disabling in older adults, but in...
peer-reviewedSarcopenia refers to the age-related decline in muscle mass. The criteria for the ident...
Background.Low lean mass is potentially clinically important in older persons, but criteria have not...
Background. Recommendations for identifying age-related muscle dysfunction have recently been publis...
Weakness is common and contributes to disability, but no consensus exists regarding a strength cutpo...
Background.Weakness is common and contributes to disability, but no consensus exists regarding a str...
Aging and menopause are associated with morphological and functional changes which may lead to loss ...
CONTEXT AND OBJECTIVE: Sarcopenia is the main factor involved in the development of frailty syndrome...